Clinical trials

Our CEO, Wout Brusselaers, was featured on OC Talks last week, a podcast from Oncology Central. In this discussion, he outlines the challenges most researchers face when finding patients for clinical trials.   He specifically addresses some of the unique challenges that come with recruiting patients for...

This week Deep 6's own Rajesh Sharma was the guest on the first episode of The Research Slayer Podcast. The episode was co-hosted by Sabrina Ramkellawan and Kim McDonald Taylor and focused on how artificial intelligence can help overcome some of the major challenges almost...

Deep 6 AI's success with Cedars-Sinai was recently discussed in an article from Nature on "An AI boost for clinical trials".   The article outlines the outdated and challenging methods researchers use to find and recruit patients for crucial clinical trials. Then the article details how software...

Cohort Builder v3.1  Deep 6 AI's Cohort Builder is a software tool researchers can use to find more, better-matching patients for clinical trials. It allows research staff to search structured and unstructured data in the Electronic Medical Record (EMR), looking at millions of documents in a...

May is Cancer Research Month so we asked our Chief Oncologist, Dr. BJ Rimel, and our lead data scientist, Scott Hoch, to shed some light on how Deep 6 is helping advance cancer research through AI-enabled Clinical Trial Acceleration Software.   Deep 6 AI: Why is oncology...

Today, on the anniversary of Robert Koch’s discovery of tuberculosis in 1882, we commemorate World Tuberculosis Day. It is a day to recognize achievements in TB prevention and control, and to renew our commitment to ending this devastating disease. In the United States, up to...

Deep 6 AI's Cohort Builder is a software tool researchers can use to assist with identifying patients for clinical trials. It allows research staff to search structured and unstructured data in the EMR; looking at millions of documents in a matter of seconds. Once you’ve...

AI Pharma In Innovation called out Deep 6 as a company that is tackling one of the hardest problems in medical research.   Did you know that 90% of drugs that reach clinical stage development never make it to FDA approval and commercialization? And that of the...